Patents by Inventor Dwight Lyman Anderson

Dwight Lyman Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240027445
    Abstract: Disclosed are methods and systems for the isolation and detection of microbes from a sample. The use of binding agents for isolation of a microbe of interest from a sample are described. In certain embodiments, the methods use ribosome-based and/or bacteriophage-based amplification of the signal in detection of bacteria and other microorganisms. For example, embodiments of the present invention can achieve total amplification of at least 10,000 from a single infected cell.
    Type: Application
    Filed: July 27, 2023
    Publication date: January 25, 2024
    Applicant: LABORATORY CORPORATION OF AMERICA HOLDINGS
    Inventors: DWIGHT LYMAN ANDERSON, ANDREW J. CONRAD, STEPHEN ERICKSON, JOSE S. GIL, BEN BARRETT HOPKINS
  • Patent number: 11873524
    Abstract: Disclosed herein are methods and systems for rapid detection of microorganisms in a sample. A genetically modified bacteriophage is also disclosed which comprises an indicator gene in the late gene region. The specificity of the bacteriophage, such as Salmonella-specific bacteriophage, allows detection of a specific microorganism, such as Salmonella spp. and an indicator signal may be amplified to optimize assay sensitivity.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: January 16, 2024
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Stephen Erickson, Jose S. Gil, Minh Mindy Bao Nguyen, Dwight Lyman Anderson, Jessica Stach
  • Publication number: 20210238559
    Abstract: Disclosed herein are methods and systems for rapid detection of microorganisms in a sample. A genetically modified bacteriophage is also disclosed which comprises an indicator gene in the late gene region. The specificity of the bacteriophage, such as CBA120, allows detection of a specific microorganism, such as E. coli O157:H7, and an indicator signal may be amplified to optimize assay sensitivity.
    Type: Application
    Filed: February 8, 2021
    Publication date: August 5, 2021
    Applicant: Laboratory Corporation of America Holdings
    Inventors: Jose S. Gil, Stephen Erickson, Ben Barrett Hopkins, Minh Mindy Bao Nguyen, Dwight Lyman Anderson
  • Publication number: 20210079443
    Abstract: Disclosed herein are methods and systems for detection of microorganisms in a sample and the utilization of such methods for selecting and monitoring therapies. The specificity of indicator bacteriophage, such as Staphylococcus-specific bacteriophage, allows detection of a specific microorganism, such as Staphylococcus and the indicator signal may be amplified to optimize assay sensitivity.
    Type: Application
    Filed: April 24, 2019
    Publication date: March 18, 2021
    Inventors: JOSE S. GIL, STEPHEN ERICKSON, MINH MINDY BAO NGUYEN, DWIGHT LYMAN ANDERSON
  • Patent number: 10913934
    Abstract: Disclosed herein are methods and systems for rapid detection of microorganisms in a sample. A genetically modified bacteriophage is also disclosed which comprises an indicator gene in the late gene region. The specificity of the bacteriophage, such as CBA120, allows detection of a specific microorganism, such as E. coli O157:H7, and an indicator signal may be amplified to optimize assay sensitivity.
    Type: Grant
    Filed: January 18, 2017
    Date of Patent: February 9, 2021
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Jose S. Gil, Stephen Erickson, Ben Barrett Hopkins, Minh Mindy Bao Nguyen, Dwight Lyman Anderson
  • Publication number: 20200140919
    Abstract: Disclosed herein are methods and systems for rapid detection of microorganisms in a sample, without culturing for enrichment of the microorganism. A modified bacteriophage is also disclosed which comprises a non-native indicator gene in the late gene region. The indicator product is not a fusion protein. The specificity of infectious agents allows a specific microorganism to be targeted, and an indicator signal may be amplified to optimize assay sensitivity.
    Type: Application
    Filed: November 5, 2019
    Publication date: May 7, 2020
    Applicant: Laboratory Corporation of America Holdings
    Inventors: Dwight Lyman Anderson, Jose S. Gil, Ben Barrett Hopkins, Stephen Erickson
  • Publication number: 20200132685
    Abstract: Disclosed herein are methods and systems for the detection of an analyte of interest by an amplified assay. The method and systems of the invention utilize the high specificity of biomolecules that have been coupled to a solid support to further amplify a signal produced by the interaction of a binding agent with the analyte of interest as a means to detect low levels of the analyte of interest present in a sample. In certain embodiments, for immunochemical (for example, ELISA or RIA) or immunofluorescence assays in which a protein to be identified is bound directly or through capture antibodies to a passivated surface, amplification of ˜10,000-fold can be achieved.
    Type: Application
    Filed: August 21, 2019
    Publication date: April 30, 2020
    Applicant: Laboratory Corporation of America Holdings
    Inventors: Dwight Lyman Anderson, Andrew J. Conrad, Stephen Erickson, Ben Barrett Hopkins
  • Patent number: 10519483
    Abstract: Disclosed herein are methods and systems for rapid detection of microorganisms in a sample, without culturing for enrichment of the microorganism. A modified bacteriophage is also disclosed which comprises a non-native indicator gene in the late gene region. The indicator product is not a fusion protein. The specificity of infectious agents allows a specific microorganism to be targeted, and an indicator signal may be amplified to optimize assay sensitivity.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: December 31, 2019
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Dwight Lyman Anderson, Jose S. Gil, Ben Barrett Hopkins, Stephen Erickson
  • Publication number: 20190218590
    Abstract: Disclosed herein are methods and systems for rapid detection of microorganisms such as Cronobacter spp. in a sample. A genetically modified bacteriophage is also disclosed which comprises an indicator gene in the late gene region. The specificity of the bacteriophage, such as Cronobacter-specific bacteriophage, allows detection of a specific microorganism, such as Cronobacter spp. and an indicator signal may be amplified to optimize assay sensitivity.
    Type: Application
    Filed: January 14, 2019
    Publication date: July 18, 2019
    Inventors: Minh Mindy Bao Nguyen, Jose S. Gil, Stephen Erickson, Dwight Lyman Anderson, Jessica Stach
  • Publication number: 20190218589
    Abstract: Disclosed herein are methods and systems for rapid detection of microorganisms in a sample. A genetically modified bacteriophage is also disclosed which comprises an indicator gene in the late gene region. The specificity of the bacteriophage, such as Salmonella-specific bacteriophage, allows detection of a specific microorganism, such as Salmonella spp. and an indicator signal may be amplified to optimize assay sensitivity.
    Type: Application
    Filed: January 14, 2019
    Publication date: July 18, 2019
    Inventors: Stephen Erickson, Jose S. Gil, Minh Mindy Bao Nguyen, Dwight Lyman Anderson, Jessica Stach
  • Patent number: 10233484
    Abstract: Disclosed herein are methods and systems for detection of a microorganism of interest using an amplification assay. The methods and systems utilize the specificity of binding agents, such as antibodies, to rapidly detect low levels of a specific microorganism present in a sample. In certain embodiments, antibodies are bound to a large number of the available binding sites on a microorganism.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: March 19, 2019
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Dwight Lyman Anderson, Ben Barrett Hopkins, Jose S. Gil, Stephen Erickson, Ekaterina Kovacheva
  • Publication number: 20170131275
    Abstract: Disclosed are methods and systems for the isolation and detection of microbes from a sample. The use of binding agents for isolation of a microbe of interest from a sample are described. In certain embodiments, the methods use ribosome-based and/or bacteriophage-based amplification of the signal in detection of bacteria and other microorganisms. For example, embodiments of the present invention can achieve total amplification of at least 10,000 from a single infected cell.
    Type: Application
    Filed: September 13, 2016
    Publication date: May 11, 2017
    Inventors: DWIGHT LYMAN ANDERSON, ANDREW J. CONRAD, STEPHEN ERICKSON, JOSE S. GIL, BEN BARRETT HOPKINS
  • Publication number: 20170121688
    Abstract: Disclosed herein are methods and systems for rapid detection of microorganisms in a sample. A genetically modified bacteriophage is also disclosed which comprises an indicator gene in the late gene region. The specificity of the bacteriophage, such as CBA120, allows detection of a specific microorganism, such as E. coli O157:H7, and an indicator signal may be amplified to optimize assay sensitivity.
    Type: Application
    Filed: January 18, 2017
    Publication date: May 4, 2017
    Inventors: Jose S. Gil, Stephen Erickson, Ben Barrett Hopkins, Minh Mindy Bao Nguyen, Dwight Lyman Anderson
  • Patent number: 9482668
    Abstract: Disclosed are methods and systems for the isolation and detection of microbes from a sample. The use of binding agents for isolation of a microbe of interest from a sample are described. In certain embodiments, the methods use ribosome-based and/or bacteriophage-based amplification of the signal in detection of bacteria and other microorganisms. For example, embodiments of the present invention can achieve total amplification of at least 10,000 from a single infected cell.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: November 1, 2016
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Dwight Lyman Anderson, Andrew J. Conrad, Stephen Erickson, Jose S. Gil, Ben Barrett Hopkins
  • Publication number: 20150233918
    Abstract: Disclosed herein are methods and systems for detection of a microorganism of interest using an amplification assay. The methods and systems utilize the specificity of binding agents, such as antibodies, to rapidly detect low levels of a specific microorganism present in a sample. In certain embodiments, antibodies are bound to a large number of the available binding sites on a microorganism.
    Type: Application
    Filed: February 18, 2015
    Publication date: August 20, 2015
    Applicant: Laboratory Corporation of America Holdings
    Inventors: Dwight Lyman Anderson, Ben Barrett Hopkins, Jose S. Gil, Stephen Erickson, Ekaterina Kovacheva
  • Publication number: 20150218616
    Abstract: Disclosed herein are methods and systems for rapid detection of microorganisms in a sample, without culturing for enrichment of the microorganism. A modified bacteriophage is also disclosed which comprises a non-native indicator gene in the late gene region. The indicator product is not a fusion protein. The specificity of infectious agents allows a specific microorganism to be targeted, and an indicator signal may be amplified to optimize assay sensitivity.
    Type: Application
    Filed: February 18, 2015
    Publication date: August 6, 2015
    Applicant: Laboratory Corporation of America Holdings
    Inventors: Dwight Lyman Anderson, Jose S. Gil, Ben Barrett Hopkins, Stephen Erickson